Humanigen, Inc. (HGEN): Price and Financial Metrics

Humanigen, Inc. (HGEN): $0.00

0.00 (-84.62%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add HGEN to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#148 of 401

in industry

HGEN Price/Volume Stats

Current price $0.00 52-week high $0.24
Prev. close $0.00 52-week low $0.00
Day low $0.00 Volume 2,063,600
Day high $0.00 Avg. volume 3,262,400
50-day MA $0.00 Dividend yield N/A
200-day MA $0.07 Market Cap 23.82K

HGEN Stock Price Chart Interactive Chart >


Humanigen, Inc. (HGEN) Company Bio


Humanigen, Inc., a clinical stage biopharmaceutical company, develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes granulocyte-macrophage colony-stimulating factor, which is in Phase Ib/II clinical trial in patients with chronic myelomonocytic leukemia, and for the treatment of juvenile myelomonocytic leukemia. It also develops Ifabotuzumab, a monoclonal antibody that targets EphA3 receptor, which has completed the Phase I dose escalation portion of a Phase I/II clinical trial in multiple hematologic malignancies; and HGEN005 an anti-EMR1 monoclonal antibody, which is in pre-clinical stage for the treatment of eosinophilic diseases. Humanigen, Inc. has a clinical collaboration agreement with Kite Pharma, Inc. to conduct a multi-center Phase Ib/II study of Lenzilumab in patients with relapsed or refractory diffuse large B-cell lymphoma; and a cooperative research and development agreement with the Department of Defense to assist in the development of lenzilumab in advance of a potential emergency use authorization for COVID-19. The company was formerly known as KaloBios Pharmaceuticals, Inc. and changed its name to Humanigen, Inc. in August 2017. Humanigen, Inc. was founded in 2000 and is based in Burlingame, California.


HGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

HGEN Latest Social Stream


Loading social stream, please wait...

View Full HGEN Social Stream

HGEN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 0.00%
3-year 0.00%
5-year N/A
YTD 0.00%
2023 -99.00%
2022 -96.77%
2021 -78.74%
2020 617.95%
2019 -30.36%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!